Hospital Wearable RFP Template & Vendor Scorecard: A Complete 2026 Toolkit
Most hospital wearable procurements do not fail during pilot. They fail months earlier, in a conference room, when the requirements document was written.
A remote patient monitoring (RPM) program gets approved. A committee is formed. Someone circulates a three-page request for proposal asking vendors for “a medical-grade wearable with ECG, SpO₂, and blood pressure, FDA cleared, with a cloud dashboard.” Fourteen vendors respond. Twelve claim to meet every requirement. The committee picks the cheapest. Eighteen months later the devices are in a drawer.
This article is the toolkit that prevents that outcome. It contains the seven modules every wearable RFP must contain, copy-paste technical specification language for five device categories, a 30-criteria vendor scorecard with suggested weightings, the clinical validation evidence you should demand, data interoperability clauses that protect you later, a total cost of ownership model, and eight red-team questions that cut through vendor marketing language.
Use it as a template. Modify it for your formulary, your EHR, and your patient population.
Why 80% of Hospital Wearable Procurement Fails at the Requirements Stage
Procurement failure in clinical wearables has a distinctive signature: the technology works, the pilot succeeds, and the program still dies. Understanding why changes how you write the RFP.
The four most common root causes
1. “Medical-grade” was never defined. This phrase appears in nearly every wearable RFP and means nothing without specifics. Medical-grade can refer to sensor accuracy against a reference standard, to a regulatory clearance, to a manufacturing quality system, or simply to a marketing claim. When the RFP does not specify which, vendors will assume the cheapest interpretation.
2. Accuracy was specified without conditions. A vendor stating “±3 bpm heart rate accuracy” has told you nothing without the conditions: at rest or during motion? On which skin tones? Across what age range? Against what reference device? Ambiguous accuracy specifications are the single most common source of post-deployment disappointment.
3. Data integration was treated as an afterthought. The device works. The data lands in a vendor portal nobody opens. Clinicians are asked to check a fourth screen, and within six weeks they stop. If your RFP does not specify how data reaches the EHR and in what format, you have purchased hardware, not a clinical capability.
4. The total cost model counted devices only. Device unit price is typically 30–45% of three-year total cost for a connected wearable program. The rest is platform licensing, cellular connectivity, replacement units, charging logistics, staff time for onboarding and support, and the cost of devices that never come back.
What this means for your RFP
Every one of these failure modes is preventable at the requirements stage, and effectively unfixable after contract signature. That is why the next section matters more than any vendor evaluation you will do later.
The 7 Modules Every Wearable RFP Must Contain
A defensible RFP separates hard requirements from preferences, states the evidence vendors must supply, and defines what happens when a requirement is only partially met.
Module 1 — Clinical Requirements and Use Case Definition
State the clinical job, not the device category. Instead of “a wearable for hypertension,” write: “ambulatory blood pressure measurement for adult patients with stage 1–2 hypertension, in a home setting, with readings transmitted to the care team for titration decisions.”
Include:
- Target patient population with relevant exclusions (e.g., atrial fibrillation, severe tremor, dialysis access)
- Clinical decision the data will inform (this determines required accuracy)
- Care workflow the device must fit into, with current-state description
- Setting of use: home, supervised facility, ambulatory, inpatient
- Expected wear duration per episode and total program duration
- Success criteria for the pilot, defined numerically before vendors respond
Module 2 — Technical Specifications
The core of the RFP. Detailed templates by device category follow in the next section. Structure each specification as: parameter, required value, test condition, and verification method.
Module 3 — Data Integration and Interoperability
Specify the destination, the standard, the format, and the latency. Include who owns the data, who may access it, and what happens to it at contract termination.
Module 4 — Regulatory and Quality Requirements
State exactly which registrations, clearances, or quality system certifications apply to your jurisdiction and use case, and require documentary evidence rather than attestations.
Module 5 — Service, Support, and SLA
Define response times, escalation paths, replacement turnaround, spare pool requirements, firmware update policy and notice period, and end-of-life notification obligations.
Module 6 — Commercial Structure
Require pricing to be broken out by component: device, platform license, connectivity, implementation, training, support tiers, and replacement units. Ask for the three-year total for a stated volume. This makes quotes comparable.
Module 7 — Exit and Transition Clauses
The most-skipped module and the one that protects you most. Cover data export format and timeline at termination, device buyback or disposal, continued platform access during transition, and escrow or continuity provisions if the vendor ceases operations.
Copy-Paste Technical Specification Template
Adapt these blocks to your requirements. The critical discipline is including test conditions and verification methods — a number without a condition is not a specification.
A. ECG-Capable Wearables
| Parameter | Required Specification | Test Condition | Verification |
|---|---|---|---|
| Lead configuration | Single-lead (Lead I equivalent) or greater | — | Device documentation |
| Sampling rate | ≥ 250 Hz | Continuous recording | Datasheet + bench test |
| Heart rate range | 30–250 bpm | Across stated range | Comparison vs. 12-lead ECG |
| Heart rate accuracy | ≤ ±5 bpm or ±5%, whichever greater | Rest and moderate activity | N=30 minimum, vs. reference ECG |
| AF detection (if claimed) | State sensitivity and specificity | Against physician-adjudicated 12-lead | Peer-reviewed publication or validation report |
| Recording duration | On-demand ≥ 30s; continuous if claimed | — | Bench test |
| Motion artifact handling | Specify acceptable signal quality during defined activity | Standardized activity protocol | Vendor validation data |
B. Pulse Oximetry Wearables
| Parameter | Required Specification | Test Condition | Verification |
|---|---|---|---|
| SpO₂ range | 70–100% | — | Datasheet |
| SpO₂ accuracy (Arms) | ≤ 3.0% across 70–100% | At rest, per ISO 80601-2-61 | Validation report |
| Accuracy across skin pigmentation | State performance by Fitzpatrick scale or equivalent | Controlled desaturation study | Clinical validation data |
| Perfusion range | State minimum perfusion index supported | Low-perfusion conditions | Bench or clinical data |
| Motion performance | State accuracy during defined motion | Standardized protocol | Validation report |
Why the skin pigmentation line matters: Pulse oximetry accuracy varies with melanin concentration, and this has been documented in both the peer-reviewed literature and regulatory safety communications. If your patient population is diverse, requiring stratified performance data is a clinical safety issue, not a procurement nicety.
C. Blood Pressure Wearables
Distinguish clearly between cuff-based and cuffless devices — they are not interchangeable, and the evidence base differs substantially.
| Parameter | Cuff-Based | Cuffless (PPG/other) |
|---|---|---|
| Validation standard | ISO 81060-2 or equivalent | State standard used; note if no validated protocol exists |
| Accuracy | Per ISO 81060-2 criteria | Request reported mean difference and SD vs. reference |
| Calibration | State interval and method | State initial and recalibration requirements |
| Population | State validated population (arm circumference, age, arrhythmia exclusions) | Same, explicitly |
| Drift | State stability over stated interval | Longitudinal data requested |
D. Continuous Temperature
| Parameter | Required Specification | Verification |
|---|---|---|
| Range | 30–43°C | Datasheet |
| Accuracy | ≤ ±0.2°C in 35–42°C | Validation report |
| Response time | State time to 90% of final reading | Bench test |
| Measurement site | Specify (wrist, axillary, core-estimating) | Documentation |
E. Multi-Parameter and General Requirements
Apply to all categories:
- Battery: State hours of continuous use per charge, charge time, charging method, and expected battery cycle life before capacity falls below 80%
- Water and dust rating: IP rating appropriate to use case; state whether suitable for showering
- Connectivity: Specify cellular (with carrier and coverage responsibility), Wi-Fi, Bluetooth gateway, or hybrid — and who pays for connectivity
- Form factor: Weight, dimensions, band sizes available, skin-contact materials
- Biocompatibility: Request ISO 10993 evaluation for skin-contact components, or documented justification for exemption
- Cleaning and disinfection: Compatible agents and validated cycle count for multi-patient use if applicable
- Accessibility: Screen, audio, haptic, and font options for patients with visual or hearing impairment
- Device management: Remote configuration, firmware update mechanism, fleet monitoring, and lost-device remote wipe
The Vendor Scorecard: 6 Dimensions, 30 Criteria
Score every responsive vendor on the same sheet before any demo. Demos are persuasive and should happen after scoring, not before.
Scoring method
Score each criterion 0–5, where 0 = does not meet, 3 = partially meets with limitations, 5 = fully meets with documentation. Multiply by weight, sum, and normalize to 100. Require a minimum threshold per dimension, not just a high total — a vendor scoring 90 with a 40 on clinical evidence should not advance.
Dimension 1 — Clinical Evidence (weight 25%, minimum threshold 60%)
- Accuracy data provided against recognized reference standard
- Validation conducted on a population matching your patient demographics
- Peer-reviewed publication or independently conducted clinical study
- Performance data in the actual use setting (home vs. supervised)
- Limitations and failure modes disclosed proactively
Dimension 2 — Technical Fit (weight 20%, minimum 60%)
- Meets all hard technical specifications
- Form factor and wearability appropriate for target population
- Battery life meets continuous-use requirement
- Connectivity model fits patient environment
- Device management and fleet monitoring capability
Dimension 3 — Data and Integration (weight 20%, minimum 60%)
- Supports required interoperability standard
- Documented, versioned API with sandbox access
- Data delivered to EHR in discrete, coded fields — not PDF attachments
- Latency meets clinical workflow requirement
- Data ownership, access control, and export rights acceptable
Dimension 4 — Regulatory and Quality (weight 15%, minimum 50%)
- Appropriate regulatory status for jurisdiction and intended use
- Manufacturing quality system certification
- Documented change control and notification process
- Adverse event reporting procedure
- Post-market surveillance and complaint handling process
Dimension 5 — Service and Operations (weight 10%, minimum 50%)
- SLA response and resolution times acceptable
- Replacement device turnaround and spare pool
- Training and onboarding scope for staff and patients
- Firmware update policy with advance notice
- End-of-life notification period ≥ 12 months
Dimension 6 — Commercial and Viability (weight 10%, minimum 50%)
- Three-year TCO within budget
- Pricing structure transparent and comparable
- Contract terms acceptable, including exit clauses
- Company financial stability and reference customers
- Reimbursement alignment with your program model
Clinical Validation: What Evidence to Demand, and How to Read It
Vendors will send you marketing documents that look like validation studies. Here is how to separate them.
What to request
- The full validation report, not a summary — including methodology, sample size, reference device, and population characteristics
- The statistical measure used: mean difference with standard deviation (Bland-Altman) is more informative than a correlation coefficient
- Subgroup performance if your population differs from the study population
- The failure cases: what percentage of readings were rejected, and why
Five things that should raise flags
- Correlation coefficient reported as the accuracy metric. Correlation measures association, not agreement. A device can correlate at r = 0.95 while systematically over-reading by 15 mmHg.
- Validation conducted by the vendor on their own employees. Not disqualifying, but independent validation carries more weight.
- Sample size under 30 subjects. Acceptable for early feasibility, not for a clinical decision support tool.
- Population demographics undisclosed. If age, skin tone, body habitus, or comorbidity profile is not stated, the results cannot be extrapolated to your patients.
- No reported failure or rejection rate. Every sensor rejects some readings. A vendor reporting 100% successful acquisition is either filtering data or not reporting honestly.
Data Integration and Interoperability Clauses
These clauses are where programs are won or lost. Adapt with your IT and compliance teams.
Minimum technical requirements
- Standard: State the required standard explicitly — HL7 FHIR R4 or later, with named resource types and profiles.
- Transport and auth: Specify OAuth 2.0 / SMART on FHIR or equivalent, TLS 1.2 minimum.
- Data elements: Enumerate the discrete fields required (observation type, value, unit, timestamp, device identifier, patient identifier, signal quality indicator).
- Latency: Define maximum acceptable delay from measurement to availability in the clinical system, by use case.
- Sandbox access: Require test environment access during evaluation, not after contract signature.
Contractual protections
Data ownership. State that patient data generated by the program remains the property of the covered entity, and that the vendor acts as a data processor.
Export on termination. Require full data export in a documented, machine-readable format within 30 days of termination, at no additional charge.
Business associate and privacy terms. Confirm the agreement covers applicable privacy regulations for your jurisdiction.
Total Cost of Ownership: The Model That Prevents Budget Surprises
Ask every vendor to complete this table for a stated patient volume over 36 months. Refuse quotes that only provide device unit price.
| Cost Component | What to Ask For | Typical Share of 3-Year TCO |
|---|---|---|
| Devices | Unit price × quantity + spares (typically 10–15% of fleet) | 30–45% |
| Platform license | Per-patient-per-month or tiered; state included seat count | 15–25% |
| Connectivity | Cellular data plan per device per month; who contracts the carrier | 5–15% |
| Implementation | Integration, configuration, EHR mapping, project management | 5–10% |
| Training | Initial and ongoing, clinical and patient-facing | 3–8% |
| Support | Tiered support cost beyond included hours | 3–8% |
| Replacement units | Expected annual attrition — ask vendors for observed rates | 5–15% |
| Logistics | Kitting, shipping, returns processing, charging infrastructure | 3–10% |
| Internal staff time | Program management, onboarding, help desk — often the largest hidden cost | 10–20% |
Red-Team Review: 8 Claims That Sound Good But Mean Nothing
Have someone outside the evaluation team review responses looking specifically for these patterns.
| # | Vendor claim | What to ask instead |
|---|---|---|
| 1 | “Medical-grade accuracy” | Against which reference standard, under what conditions, in which population? |
| 2 | “FDA registered” | Registration is not clearance. Is the specific device cleared for the specific intended use? Provide the 510(k) number. |
| 3 | “Clinically validated” | By whom, published where, with what sample size and endpoints? |
| 4 | “Seamless EHR integration” | Which EHR versions, which FHIR resources, live at how many sites? Provide references. |
| 5 | “AI-powered insights” | What is the algorithm’s intended use, validation performance, and change control process? |
| 6 | “Unlimited users” | Unlimited concurrent or named? What happens at peak? |
| 7 | “HIPAA compliant” | Provide the BAA, the most recent independent security assessment, and data residency details. |
| 8 | “99.9% uptime” | Measured how, over what period, with what exclusions and remedies? |
Putting the Toolkit to Work: A Practical Sequence
- Week 1–2: Define the clinical use case and success criteria with clinicians. Do not involve vendors yet.
- Week 3: Draft the RFP using the seven modules. Circulate to IT, compliance, biomedical engineering.
- Week 4: Issue the RFP. Require responses in your format, not the vendor’s. Give a minimum 3-week response window.
- Week 7–8: Score all responses with the 30-criteria sheet before scheduling any demo. Set dimension thresholds in advance.
- Week 9: Run structured demos with the shortlist, using the same scripted scenarios for each vendor.
- Week 10: Request validation reports, security documentation, and reference calls. Check references without the vendor present.
- Week 11–12: Negotiate, with particular attention to exit clauses and data export terms.
- Pilot: Run a defined pilot with pre-agreed numerical success criteria and a decision gate at the end.
Frequently Asked Questions
What technical specifications should a hospital RFP for wearable devices include?
At minimum: sensor accuracy against a named reference standard with stated test conditions, validated population characteristics, sampling rate or measurement interval, battery life under continuous use, connectivity model and who bears the cost, data output format and interoperability standard, biocompatibility documentation for skin-contact materials, device management capabilities, and expected service life. Each specification should state the verification method.
How can hospitals objectively evaluate the clinical accuracy of wearable vendors?
Request the full validation report rather than a summary, and look for mean difference with standard deviation (Bland-Altman analysis) rather than correlation coefficients. Check that the study population matches your patient demographics. Ask for the percentage of readings rejected and why. Independent or peer-reviewed validation carries more weight than vendor-conducted studies alone.
What is a reasonable budget range for RPM device procurement?
Device hardware typically represents 30–45% of three-year total cost of ownership. The remainder is platform licensing, cellular connectivity, implementation, training, support, replacement units for attrition, logistics, and internal staff time. Rather than comparing device unit prices, request a three-year total cost for a stated patient volume across a standardized cost table.
What standards must wearable devices meet to integrate with hospital EHR systems?
Specify HL7 FHIR R4 or later with named resource types and profiles, and require the vendor to provide their implementation guide or CapabilityStatement. Require test environment access during evaluation. Critically, specify that data must arrive as discrete coded fields rather than PDF attachments.
How much weight should regulatory and compliance credentials carry in a vendor scorecard?
We suggest 15% of total score with a minimum threshold of 50% on that dimension alone, enforced independently of the total. A vendor with excellent clinical evidence but no appropriate regulatory status for your jurisdiction and intended use is not viable regardless of total score. Always require documentary evidence.
Building a wearable procurement program and need device specification data for your RFP? Our team can provide technical documentation, validation summaries, and integration specifications for the device categories discussed here. Contact us to request a specification pack.